MedPath

Hip Fractures Treated With Uncemented Arthroplasties

Phase 2
Conditions
Femoral Neck Fractures
Registration Number
NCT01798472
Lead Sponsor
Stockholm South General Hospital
Brief Summary

The aim of this study is to compare the functional and radiological outcome after displaced, femoral neck fractures treated with either cemented or uncemented arthroplasties.

The primary hypothesis is that the uncemented arthroplasty shows the same functional outcome at 12 month as the cemented arthroplasty.

Detailed Description

Femoral neck fracture is a common cause of suffering and premature mortality among the elderly. Riskfactors for femoral neck fractures are age, gender, osteoporosis and cognitive dysfunction.

Mortality and morbidity varies between undisplaced and displaced femoral neck fractures.

Different treatment options are available: reduction and internal fixation vs joint replacement (arthroplasty). The treatment of undisplaced femoral neck fractures is uncontroversial and consists of internal fixation with screws.

The treatment of displaced, femoral neck fractures with internal fixation shows unacceptable results with complications rates leading to reoperation between 40-60%. Treatment of these fractures with arthroplasties has therefore become the standard treatment in industrial countries.

Fixation of the femoral component with bone-cement is standard procedure in Europe today. To avoid negative cardio-pulmonary events in patients with serious comorbidities and in very old and frail patients uncemented femoral components or internal fixation are used. These uncemented stems are mostly older design with poor track records. The use of modern, well-documented stems used in an osteoarthritis population for fracture patients has still to be tested.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
140
Inclusion Criteria
  • displaced fracture of the femoral neck
  • independent living
  • independent ambulation (with or without walking aids)
Exclusion Criteria
  • pathological fracture
  • severe dementia (defined as ≤3 in short portable mental questionnaire) preoperatively
  • preexisting ipsilateral hip disease
  • neurological disease (e.g. M. Parkinson)
  • psychiatric disease which makes understanding or following instructions impossible
  • history of drug and alcohol abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Harris Hip Score12 month

Our primary outcome variable is the Harris Hip Score at 12 month follow up. Harris Hip Score is an investigator reported tool evaluating hip function in four dimensions:

Pain, function, absence of deformity and range of motion

Secondary Outcome Measures
NameTimeMethod
Health related quality of life12 month

We use the patient reported instrument EQ-5D. A questionnaire consisting of 5 questions to evaluate health related quality of life.

Radiological follow up12 month

Evaluation of radiological outcome on standard hip radiographies with focus on bony ingrowth, signs of loosening and subsidence

Trial Locations

Locations (1)

Södersjukhuset (South general hospital), Department of orthopedic surgery

🇸🇪

Stockholm, Sweden

Södersjukhuset (South general hospital), Department of orthopedic surgery
🇸🇪Stockholm, Sweden
Christian Inngul, M.D.
Principal Investigator
Anders Enocson, M.D. Ph.D.
Sub Investigator
Richard Blomfeldt, M.D. Ph.D.
Sub Investigator
Sari Ponzer, M.D. Prof
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.